Usutu Virus

Transfusion Medicine and Hemotherapy

Volumn 41, Issue 1, 2014, Pages 73-82

  Seitz, Rainer ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; VIRUS ANTIBODY; VIRUS RNA; VIRUS VACCINE;

ANTIBODY DETECTION; ANTIVIRAL THERAPY; ARBOVIRUS; ARTICLE; BLOOD DONOR; CHEMOPROPHYLAXIS; CROSS REACTION; DISEASE COURSE; DISEASE SEVERITY; FLAVIVIRUS; GENETIC ANALYSIS; IMMUNE STATUS; INCIDENCE; MOSQUITO; NONHUMAN; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; USUTU VIRUS; USUTU VIRUS INFECTION; VIRUS DETECTION; VIRUS GENOME; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

EID: 84925867058     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000357106     Document Type: Article

References (81)

1. Williams MC, Simpson DI, Haddow AJ, Knight EM: The isolation of West Nile Virus from man and of Usutu virus from the bird-biting mosquito Mansonia aurites (Theobald) in the Entebbe area of Uganda. Ann Trop Med Parasitol 1964;58:367-374.
2. CRORA Senegal: www.pasteur.fr/recherche/banques/CRORA/souches/sras1.html (retrieved 14 Sept 2012
3. CRORA RCA: www.pasteur.fr/recherche/banques/CRORA/souches/sqas1.html (retrieved 14 Sept 2012
4. Woodall JP: The viruses isolated from arthropods at the East African Virus Research Institute in the years ending December 1963. Proc E Afr Acad 1964;II:141-146.
5. CRORA Flavivirus USUTU: www.pasteur.fr/recherche/banques/CRORA/virus/v010050.html (retrieved 14 Sept 2012
6. CDC Arbocat USUV: www.cdc.gov/arbocat/catalog-listing.asp?VirusID=503&SI=1 (retrieved 19 Sept 2012
7. Nikolay B, Diallo M, Boye CS, Sall AA: Usutu virus in Africa. Vector Borne Zoonotic Dis 2011; 11:1417-1423.
8. Kilpatrick AM, Kramer LD, Jones MJ, Marra PP, Daszak P: West Nile virus epidemics in North America are driven by shifts in mosquito feeding behavior. PLoS Biol 2006;4:e82.
9. Pauli G, Bauerfeind U, Blümel J, et al: West-Nil-Virus. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2012;55:1024-1043.
10. Becker N, Jöst H, Ziegler U, et al: Epizootic emergence of Usutu virus in wild and captive birds in Germany. PLoS One 2012;7:e32604.
11. Allering L, Jöst H, Emmerich P, et al: Detection of Usutu virus infection in a healthy blood donor from south-west Germany, 2012. Euro Surveill 2012;17:pii = 20341; available online: www.eurosurveillance. org/ViewArticle.aspx?ArticleId=20341.
12. Weissenböck H, Hubálek Z, Bakonyi T, Nowotny N: Zoonotic mosquito-borne flaviviruses: worldwide presence of agents with proven pathogenicity and potential candidates of future emerging diseases. Vet Microbiol 2010;140:271-280.
13. Gürtler L, Bauerfeind U, Blümel J, et al: Dengue Fieber Virus (DENV). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2011;54:892-904.
14. Kreil TR, Berting A, Kistner O, Kindermann J: West Nile virus and the safety of plasma derivatives: verification of high safety margins, and the validity of predictions based on model virus data. Transfusion 2003;43:1023-1028.
15. Song H, Li J, Shi S, Yan L, Zhuang H, Li K: Thermal stability and inactivation of hepatitis C virus grown in cell culture. Virol J 2010;7:40.
16. Fang Y, Brault AC, Reisen WK: Comparative thermostability of West Nile, St. Louis encephalitis, and western equine encephalomyelitis viruses during heat inactivation for serologic diagnostics. Am J Trop Med Hyg 2009;80:862-863.
17. Xie YW, Chan PK, Szeto CK, et al: Clearance of dengue virus in the plasma-derived therapeutic proteins. Transfusion 2008;48:1342-1347.
18. Remington KM, Trejo SR, Buczynski G, et al: Inactivation of West Nile virus, vaccinia virus and viral surrogates for relevant and emergent viral pathogens in plasma-derived products. Vox Sang 2004;87:10-18.
19. Kreil TR: West Nile virus: recent experience with the model virus approach. Dev Biol (Basel) 2004; 118:101-105.
20. Weissenböck H, Chvala S, Bakonyi T, Nowotny N: Emergence of Usutu virus in central Europe: diagnosis, surveillance and epizoology; in Takken W, Knols B (eds): Emerging Pests and Vector-Borne Disease in Europe. Wageningen, Wageningen Academic Publishers, 2007, pp 153-168.
21. Pecorari M, Longo G, Gennari W, et al: First human case of Usutu virus neuroinvasive infection, Italy, August-September 2009. Euro Surveill 2009; 14:pii = 19446.
22. Cavrini F, Gaibani P, Longo G, et al: Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August-September 2009. Euro Surveill 2009;14:pii = 19448.
23. Cavrini F, Della Pepa ME, Gaibani P, et al: A rapid and specific real-time RT-PCR assay to identify Usutu virus in human plasma, serum, and cerebrospinal fluid. J Clin Virol 2011;50:221-223.
24. Gaibani P, Pierro A, Alicino R, et al: Detection of Usutu-virus-specific IgG in blood donors from northern Italy. Vector Borne Zoonotic Dis 2012;12: 431-433.
25. Chvala S, Kolodziejek J, Nowotny N, Weissenböck H: Pathology and viral distribution in fatal Usutu virus infections of birds from the 2001 and 2002 outbreaks in Austria. J Comp Pathol 2012;131:176-185.
26. Weissenböck H, Bakonyi T, Chvala S, Nowotny N: Experimental Usutu virus infection of suckling mice causes neuronal and glial cell apoptosis and demyelination. Acta Neuropathol 2004;108:453-460.
27. Morrey JD, Olsen AL, Siddharthan V, et al: Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents. J Gen Virol 2008;89:467-473.
28. Simpson DIH, O'Sullivan JP: Studies on arboviruses and bats (Chiroptera) in East Africa. I. Experimental infection of bats and virus transmission attempts in Aedes (Stegomyia) aegypti. Ann Trop Med Parasit 1968;62:422-431.
29. Chvala S, Bakonyi T, Hackl R, Hess M, Nowotny N, Weissenböck H: Limited pathogenicity of Usutu virus for the domestic goose (Anser anser f. domestica) following experimental inoculation. J Vet Med B Infect Dis Vet Public Health 2006;53:171-175.
30. Chvala S, Bakonyi T, Bukovsky C, et al: Monitoring of Usutu virus activity and spread by using dead bird surveillance in Austria, 2003-2005. Vet Microbiol 2007;122:237-245.
31. Chevalier V, Lecollinet S, Durand B: West Nile virus in Europe: a comparison of surveillance system designs in a changing epidemiological context. Vector Borne Zoonotic Dis 2011;11:1085-1091.
32. Weissenböck H, Kolodziejek J, Url A, Lussy H, Rebel-Bauder B, Nowotny N: Emergence of Usutu virus, an African mosquito-borne flavivirus of the Japanese encephalitis virus group, central Europe. Emerg Infect Dis 2002;8:652-656.
33. Brugger K, Rubel F: Simulation of climate-change scenarios to explain Usutu-virus dynamics in Austria. Prev Vet Med 2009;88:24-31.
34. Meister T, Lussy H, Bakonyi T, et al: Serological evidence of continuing high Usutu virus (Flaviviridae) activity and establishment of herd immunity in wild birds in Austria. Vet Microbiol 2007;127:237-248.
35. Bakonyi T, Erdélyi K, Ursu K, et al: Emergence of Usutu virus in Hungary. J Clin Microbiol 2007;45: 3870-3874.
36. Steinmetz HW, Bakonyi T, Weissenböck H, et al: Emergence and establishment of Usutu virus infection in wild and captive avian species in and around Zurich, Switzerland-genomic and pathologic comparison to other central European outbreaks. Vet Microbiol 2011;148:207-212.
37. Tamba M, Bonilauri P, Bellini R, et al: Detection of Usutu virus within a West Nile virus surveillance program in Northern Italy. Vector Borne Zoonotic Dis 2011;11:551-557.
38. Weissenböck H, Kolodziejek J, Fragner K, Kuhn R, Pfeffer M, Nowotny N: Usutu virus activity in Austria, 2001-2002. Microbes Infect 2003;5:1132-1136.
39. Jöst H, Bialonski A, Maus D, et al: Isolation of Usutu virus in Germany. Am J Trop Med Hyg 2011;85:551-553.
40. Busquets N, Alba A, Allepuz A, Aranda C, Ignacio Nuñez J: Usutu virus sequences in Culex pipiens (Diptera: Culicidae), Spain. Emerg Infect Dis 2008;14:861-863.
41. Vázquez A, Ruiz S, Herrero L, et al: West Nile and Usutu viruses in mosquitoes in Spain, 2008-2009. Am J Trop Med Hyg 2011;85:178-181.
42. Lupulovic D, Martín-Acebes MA, Lazic S, et al: First serological evidence of West Nile virus activity in horses in Serbia. Vector Borne Zoonotic Dis 2011;11:1303-1305.
43. Hubálek Z, Halouzka J, Juricová Z, et al: Serologic survey of birds for West Nile flavivirus in southern Moravia (Czech Republic). Vector Borne Zoonotic Dis 2008a;8:659-666.
44. Hubálek Z, Wegner E, Halouzka J, et al: Serologic survey of potential vertebrate hosts for West Nile virus in Poland. Viral Immunol 2008b;21:247-253.
45. Rizzoli A, Rosá R, Rosso F, Buckley A, Gould E: West Nile virus circulation detected in northern Italy in sentinel chickens. Vector Borne Zoonotic Dis 2007;7:411-417.
46. Lelli R, Savini G, Teodori L, et al: Serological evidence of Usutu virus occurrence in north-eastern Italy. Zoonoses Public Health 2008;55:361-367.
47. Savini G, Monaco F, Terregino C, et al: Usutu virus in Italy: an emergence or a silent infection? Vet Microbiol 2011;15:264-274.
48. Manarolla G, Bakonyi T, Gallazzi D, et al: Usutu virus in wild birds in northern Italy. Vet Microbiol 2010;141:159-163.
49. Calzolari M, Gaibani P, Bellini R, et al: Mosquito, bird and human surveillance of West Nile and Usutu viruses in Emilia-Romagna region (Italy) in 2010. PLoS One 2012;7:e38058.
50. Bakonyi T, Gould EA, Kolodziejek J, Weissenböck H, Nowotny N: Complete genome analysis and molecular characterization of Usutu virus that emerged in Austria in 2001: comparison with the South African strain SAAR-1776 and other flaviviruses. Virology 2004;328:301-310.
51. Hayes EB, Komar N, Nasci RS, Montgomery SP, O'Leary DR, Campbell GL: Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis 2005;20:1167-1173.
52. Linke S, Niedrig M, Kaiser A, et al: Serologic evidence of West Nile virus infections in wild birds captured in Germany. Am J Trop Med Hyg 2007; 77:358-364.
53. Bakonyi T, Ivanics E, Erdélyi K, et al: Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe. Emerg Infect Dis 2006;12:618-623.
54. Calistri P, Giovannini A, Hubálek Z, et al: Epidemiology of West Nile in Europe and in the Mediterranean basin. Open Virol J 2010;4:29-37.
55. Becker N, Huber K, Pluskota B, Kaiser A: Ochlerotatus japonicus japonicus-A newly established neozoan in Germany and a revised list of the German mosquito fauna. Eur Mosq Bull 2011;29:88-102.
56. Janusz KB, Lehman JA, Panella AJ, Fischer M, Staples E: Laboratory testing practices for West Nile virus in the United States. Vector Borne Zoonotic Dis 2011;11:597-599.
57. Linke S, Muehlen M, Niedrig M, et al: Assessing the exposure of German and Austrian bird ringers to West Nile virus (Flavivirus) and evaluating their potential risk of infection. J Ornithol 2008;149:271-275.
58. Pfleiderer C, Blümel J, Schmidt M, et al: West Nile virus and blood product safety in Germany. J Med Virol 2008;80:557-563.
59. Papa A, Xanthopoulou K, Gewehr S, Mourelatos S: Detection of West Nile virus lineage 2 in mosquitoes during a human outbreak in Greece. Clin Microbiol Infect 2011;17:1176-1180.
60. Bakonyi T, Lussy H, Weissenböck H, Hornyák A, Nowotny N: In vitro host-cell susceptibility to Usutu virus. Emerg Infect Dis 2005;11:298-301.
61. Essbauer SS, Krautkrämer E, Herzog S, Pfeffer M: A new permanent cell line derived from the bank vole (Myodes glareolus) as cell culture model for zoonotic viruses. Virol J 2011;8:339.
62. Scaramozzino N, Crance JM, Jouan A, et al: Comparison of Flavivirus universal primer pairs and development of a rapid, highly sensitive heminested reverse transcription-PCR assay for detection of flaviviruses targeted to a conserved region of the NS5 gene sequences. J Clin Microbiol 2001;39:1922-1927.
63. Maher-Sturgess SL, Forrester NL, Wayper PJ, et al: Universal primers that amplify RNA from all three flavivirus subgroups. Virol J 2008;5:16.
64. Johnson N, Wakeley PR, Mansfield KL, et al: Assessment of a novel real-time pan-flavivirus RTpolymerase chain reaction. Vector Borne Zoonotic Dis 2010;10:665-671.
65. Ravanini P, Huhtamo E, Ilaria V, et al: Japanese encephalitis virus RNA detected in Culex pipiens mosquitoes in Italy. Euro Surveill 2012;17:pii = 20221.
66. Platonov AE, Rossi G, Karan LS, Mironov KO, Busani L, Rezza G: Does the Japanese encephalitis virus (JEV) represent a threat for human health in Europe Detection of JEV RNA sequences in birds collected in Italy. Euro Surveill 2012;17:pii = 20241.
67. Vlachakis D: Theoretical study of the Usutu virus helicase 3D structure, by means of computer-Aided homology modelling. Theor Biol Med Model 2009; 6:9.
68. Malet H, Massé N, Selisko B, et al: The flavivirus polymerase as a target for drug discovery. Antiviral Res 2008;80:23-35.
69. Diamond MS: Progress on the development of therapeutics against West Nile virus. Antiviral Res 2009;83:214-227.
70. Beasley DW: Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus. Immunotherapy 2011;3:269-285.
71. Montgomery SP, Brown JA, Kuehnert M, et al; 2003 West Nile Virus Transfusion-Associated Transmission Investigation Team: Transfusion-Associated transmission of West Nile virus, United States 2003 through 2005. Transfusion 2006;46:2038-2046.
72. CDC, Centers for Disease Control and Prevention: West Nile virus transmission through blood transfusion-South Dakota, 2006. MMWR Morb Mortal Wkly Rep 2007;56:76-79.
73. Jakubik JJ, Vicik SM, Tannatt MM, Kelley BD: West Nile Virus inactivation by the solvent/detergent steps of the second and third generation manufacturing processes for B-domain deleted recombinant factor VIII. Haemophilia 2004;10:69-74.
74. Hellstern P, Solheim BG: The use of solvent/detergent treatment in pathogen reduction of plasma. Transfus Med Hemother 2011;38:65-70.
75. Mohr H, Knüver-Hopf J, Gravemann U, Redecker-Klein A, Müller TH: West Nile virus in plasma is highly sensitive to methylene blue-light treatment. Transfusion 2004;44:886-890.
76. Lin L, Hanson CV, Alter HJ, et al: Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light. Transfusion 2005;45:580-590.
77. Gallian P, Vignoli C, Dombey AM, et al: Inactivation of a European strain of West Nile virus in single-donor platelet concentrate using the INTERCEPT blood system. Vox Sang 2006;91:345-347.
78. Irsch J, Lin L: Pathogen inactivation of platelet and plasma blood components for transfusion using the INTERCEPT Blood System™. Transfus Med Hem other 2011;38:19-31.
79. Marschner S, Goodrich R: Pathogen reduction technology treatment of platelets, plasma and whole blood using riboflavin and UV light. Transfus Med Hemother 2011;38:8-18.
80. Solheim BG: Pathogen reduction of blood components. Transfus Apher Sci 2008;39:75-82.
81. Rock G: A comparison of methods of pathogen inactivation of FFP. Vox Sang 2011;100:169-178.